Cross-institution positioning
Aug 13, 2026Accumulation leaning. 1 accumulating across 1 comparable institution.
Source: Schedule 13 researchZEPP Institutional Ownership
Zepp Health Corp
Latest stored close $3.84 as of Oct 8, 2026 View live quote ↗
STOCKNODE Outlook
Neutral
56/100
1 tracked · 1 comparable
Latest filing
Aug 13, 2026
Positive breadth
1 positive · 0 negative
Recent close
$3.84
Research confidence
Limited
Institutional Research 71/100 · 1 accumulating · 0 reducing / exited
Ownership history
Reported ownership % history
Latest filing Aug 13, 2026
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
Locked preview
Unlock the reported ownership timeline
Unlock full research
Accumulating1
Newly reported0
Reducing / exited
0
52-week position
—
Institutional Intelligence
Why STOCKNODE says Neutral
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
STOCKNODE Outlook
Neutral 56/100
Confidence:Limited
Why this signal
- 1 tracked institution accumulating versus 0 reducing/exited.
- Comparable SEC fundamentals are improving.
Institutional
58/100
Insiders
42/100
Fundamentals
63/100
Quarterly 13F activity
Jun 30, 20260 increased/new, 1 reduced/exited across 1 manager in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsInsider filing activity
Sep 24, 2026Over the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 2 sales by 1 reporting owner. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/5SEC fundamentals
Apr 24, 2026Revenue +41.8% YoY; Net income +47.1% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsPrice context
Sep 15, 2026Recent close is 1% through its reported 52-week range; -91.0% over one year.
Source: Stored historical price series
Latest filing decision brief
Investor / Pro
Research the latest Schedule 13G amendment from Morgan Stanley.
Filed Aug 13, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
Supporting institutional evidence
Institutional Evidence
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
Latest filing
Aug 13, 2026
Latest reported position changes
Investor / Pro detailSee each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Morgan Stanley
Filed Aug 13, 2026
Direction locked
Unlock the actual direction, share change, ownership change, and classification basis.
No premium position values are sent in this locked preview.
Unlock full research
Reported direction breadth by as-of date
Locked previewComparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Unlock actual accumulation vs. reduction breadth across reported position dates.
View plans
Institution comparison
Investor / Pro detailCompare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Morgan Stanley
Filed Aug 13, 2026
Unlock the evidence behind the score
Know who changed position, by how much, and when the SEC learned about it.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
✓ Actual share and ownership changes
✓ Position as-of date vs. SEC filed date
✓ Deterministic direction basis
✓ Full evidence on every eligible stock
SEC Forms 3, 4 & 5
Insider activity
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
30-day purchases00 reporting owner(s)
30-day sales21 reporting owner(s)
90-day purchase breadth0
90-day sale breadth1
View recent insider filing evidence
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | Yu Pengtao | SOpen-market or private sale | American depositary shares | 4.3K | $4.09 | Direct | Sep 25, 2026 |
| Sep 23, 2026 | Yu Pengtao | SOpen-market or private sale | American depositary shares | 5.7K | $4.30 | Direct | Sep 25, 2026 |
| Jun 26, 2026 | FAN Meihui | MExercise or conversion of derivative · derivative | Options (right to buy) | 80.0K | $0.00 | Direct | Jun 30, 2026 |
| Jun 26, 2026 | FAN Meihui | MExercise or conversion of derivative · derivative | Options (right to buy) | 80.0K | $0.00 | Direct | Jun 30, 2026 |
| Jun 26, 2026 | FAN Meihui | MExercise or conversion of derivative · derivative | Options (right to buy) | 200.0K | $0.00 | Direct | Jun 30, 2026 |
| Jun 26, 2026 | FAN Meihui | MExercise or conversion of derivative · derivative | Options (right to buy) | 160.0K | $0.00 | Direct | Jun 30, 2026 |
| Jun 26, 2026 | FAN Meihui | MExercise or conversion of derivative | Class A ordinary shares | 520.0K | $0.00 | Indirect | Jun 30, 2026 |
| Jun 26, 2026 | Deng Cheng | MExercise or conversion of derivative · derivative | Restricted Share Units | 366.0K | $0.00 | Direct | Jun 29, 2026 |
| Jun 26, 2026 | Deng Cheng | SOpen-market or private sale | American depositary shares | 9.8K | $4.61 | Direct | Jun 29, 2026 |
| Jun 26, 2026 | Deng Cheng | MExercise or conversion of derivative | American depositary shares | 22.9K | $0.00 | Direct | Jun 29, 2026 |
| Apr 1, 2026 | Deng Cheng | AGrant, award, or other acquisition · derivative | Restricted Share Units | 366.0K | $0.00 | Direct | Jun 29, 2026 |
SEC-reported company fundamentals
Fundamentals
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
Revenue
$258.9M
FY 2025
+41.8% YoY 20-F filed Apr 24, 2026
Operating income
$-29.2M
FY 2025
+38.1% YoY 20-F filed Apr 24, 2026
Operating margin
-11.3%
FY 2025
+14.6 pts YoY 20-F filed Apr 24, 2026
Net income
$-40.1M
FY 2025
+47.1% YoY 20-F filed Apr 24, 2026
Diluted EPS
$-0.16
FY 2025
+44.8% YoY 20-F filed Apr 24, 2026
Operating cash flow
$-25.7M
FY 2025
-5.3% YoY 20-F filed Apr 24, 2026
Free cash flow
$-26.2M
FY 2025
-1.6% YoY 20-F filed Apr 24, 2026
Cash & equivalents
$57.0M
As of Dec 31, 2025
-37.4% YoY 20-F filed Apr 24, 2026
Assets
$564.8M
As of Dec 31, 2025
+6.9% YoY 20-F filed Apr 24, 2026
Liabilities
$350.3M
As of Dec 31, 2025
+27.0% YoY 20-F filed Apr 24, 2026
Stockholders’ equity
$214.5M
As of Dec 31, 2025
-14.7% YoY 20-F filed Apr 24, 2026
View recent revenue trend
Annual
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 31, 2025 | $258.9M | +41.8% |
| Ended Dec 31, 2024 | $182.6M | -48.3% |
| Ended Dec 31, 2023 | $352.9M | -42.5% |
| Ended Dec 31, 2023 | 2.5B CNY | — |
Current market context
Price performance
Dated price context from the historical market series already collected for this security.
Recent stored close
$4.33
View live quote ↗
52-week low
$3.85
Jun 10, 2026
52-week high
$61.85
Oct 9, 2025
Below 52-week high
93.0%
1W return
-12.0%
1M return
-20.1%
3M return
-14.1%
6M return
-79.2%
YTD return
-83.9%
1Y return
-91.0%
30-day volatility
71.1%
90-day volatility
113.3%
1Y max drawdown
-93.5%
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
How to read Schedule 13 ownership changes
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
Current ownership filings and reported ownership changes are available on free access. Investor and Pro add filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and alerts. The overall institutional consensus preview remains public. Compare plans.
Beneficial ownership filing history
Showing 3 of 4 filing(s) · 1 older require more history accessView beneficial ownership filing evidence
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Morgan Stanley CIK0000895421 | Jun 30, 2026 observed Aug 13, 2026 filed · 44d Schedule 13G amendment | Reported shares unchanged | 11.9M 0 | 8.80% 0.00 pts | $5.21 | $5.36 | $3.84 |
| Morgan Stanley CIK0000895421 | Jun 30, 2026 observed Aug 12, 2026 filed · 43d Schedule 13G amendment | Reported accumulation | 11.9M +3.4M | 8.80% +1.30 pts | $5.21 | $5.45 | $3.84 |
| Morgan Stanley CIK0000895421 | Sep 30, 2025 observed Jun 26, 2026 filed · 269d Initial Schedule 13G | Initial Schedule 13G | 8.5M | 7.50% | $45.78 | $4.49 | $3.84 |
Explore more institutional activity
Related research
Compare ZEPP with other securities showing similar institutional activity or recent accumulation across several tracked institutions.